SEC Form 4 · accession 0001140361-16-069995
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Jun 15, 2016
Accepted (ET)
Jun 16, 2016 · 2:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF2 | Jun 15, 2016 | M | 5,975 | $33.70 | A | 154,814 | D | |
| ResMed Common Stock | Jun 15, 2016 | S | 5,975 | $59.63 | D | 148,839 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF3 | $33.70 | Jun 15, 2016 | M | 5,975 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Commmon Stock | 5,975 | 27,200 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.
- F2Includes 90.66 shares of ResMed stock purchased on 5/5/2016, through the ResMed Employee Stock Purchase Plan.
- F3Represents date options first became exercisable. Options vest 1/4 per year.